| Patent(s) and the Corresponding Patented Drug(s) |
Top |
| World Intellectual Property Organization (WIPO) |
| Patent ID |
WO2015089153 |
| Title |
Treatment of Multiple Sclerosis with A 1,2,4-Triazolo [1,5A] Pyridine Derivative. |
| Abstract |
The present disclosure provides methods and compositions for treating chronic autoimmune diseases, such as multiple sclerosis, using [8-(4-methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-[3-(4-methyl-piperazin-1-yl)-phenyl]-amine or a pharmaceutically acceptable salt thereof. |
| Applicant(s) |
Cephalon, Inc |
| Representative Drug(s) |
D07XYI |
Drug Info
|
IC50 = 1100 nM |
[1] |
| Patent ID |
WO2014091265 |
| Title |
Pyrimidine-2,4-Diamine Derivatives As Kinase Inhibitors. |
| Abstract |
The present application relates to novel Pyrimidine-2,4-diamine derivatives as kinase inhibitors derivatives of formula (I), as protein kinase inhibitors. Formula (I). The invention particularly relates to compounds of formula (I), preparation of compounds and pharmaceutical compositions thereof. The invention further relates to prodrugs, derivatives, polymorphs, pharmaceutically acceptable salts and compositions comprising the said novel Pyrimidine-2,4-diamine derivatives as kinase inhibitors and their derivatives and their use in the treatment of various disorders. |
| Applicant(s) |
Aurigene Discovery Technologies Limited |
